Phesgo logo
WebAug 8, 2024 · Phesgo contains a combination of hyaluronidase, pertuzumab, and trastuzumabis. Phesgo is a cancer medicine that is used alone or with other medicines to … WebPolicy. Precertification of pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo) is required of all Aetna participating providers and members in applicable plan designs. For precertification of pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo), call (866) 752-7021 (Commercial), (866) 503-0857 (Medicare), or fax (888) 267-3277.
Phesgo logo
Did you know?
WebJun 29, 2024 · The safety profile of PHESGO is comparable to intravenous pertuzumab and trastuzumab, except for increased administration-related reactions. The most common adverse reactions in >30% patients... WebPhesgo® contains pertuzumab, trastuzumab, and hyaluronidase-zzxf. It is best to read this information with our general information about breast cancer. These treatments belong to a group of targeted therapy drugs known as monoclonal antibodies. They both work by targeting specific proteins (receptors).
WebJun 29, 2024 · SAN DIEGO, June 29, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has approved Roche's Phesgo™ (pertuzumab,... WebOct 13, 2024 · PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf) injection is a sterile, preservative-free, clear to opalescent, and colorless to slightly brownish solution …
WebJun 23, 2024 · Dosage. Phesgo dosage. For intravenous infusion only. Do not administer as an intravenous push or bolus. HER2 testing: Perform using FDA-approved tests by laboratories with demonstrated proficiency.. The initial Pertuzumab dose is 840 mg administered as a 60-minute intravenous infusion, followed every 3 weeks thereafter by … WebMar 1, 2024 · PHESGO is made up of two medicines combined together that belong to a group of medicines called monoclonal antibodies (pertuzumab and trastuzumab). • PHESGO recognizes the cancer cells in the body called “human epidermal growth factor …
WebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body … Most common side effects of PHESGO and tips you can try. The most common side … Taking PHESGO - PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) A … Patient Resources - PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) A … PHESGO may cause administration-related reactions: PHESGO is given as an … What is Phesgo - PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) A … Questions For Your Care Team - PHESGO® (pertuzumab / trastuzumab / …
WebPHESGO administration can result in serious and fatal pulmonary toxicity. Discontinue PHESGO for anaphylaxis, angioedema, interstitial pneumonitis, or acute respiratory … shopeefood driver centerWebPhesgo is a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection in combination with intravenous (IV) chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer. This is the first time that Roche has combined two ... shopeefood general terms and conditionsWebMar 25, 2024 · This Phase III, randomized, two-arm, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus Phesgo compared with Phesgo after induction therapy with Phesgo plus taxane in participants with human epidermal growth factor receptor 2 (HER2)-positive, estrogen receptor (ER)-positive advanced breast cancer … shopeefood driver center cilandakWebPhesgo is a combination medication containing pertuzumab, trastuzumab, and hyaluronidase or hyaluronidase-zzxf. It's a targeted anticancer treatment for HER2-positive breast cancer that’s either in the early or metastatic stage. Phesgo is an injection that’s given under the skin, and it’s typically used along with other chemotherapy. shopeefood customer serviceWebPhesgo® contains two separate monoclonal antibodies, trastuzumab and pertuzumab. Previously, trastuzumab and pertuzumab were used separately or in combination to … shopeefood daftarWebIf PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. shopeefood jombangWebJan 18, 2024 · Associate Professor. Department of Physics and Astronomy. SUNY College at Geneseo. 1 College Circle. Geneseo, NY 14454. Office: ISC 228D. Email pogo. Pogo & … shopeefood hub